Literature DB >> 29174537

Flow cytometry-based method for rapid and high-throughput screening of hybridoma cells secreting monoclonal antibody.

Sachi Akagi1, Chika Nakajima2, Yoichiro Tanaka3, Yasuyuki Kurihara4.   

Abstract

Monoclonal antibodies (mAbs) are a valuable biomaterial for basic life sciences and industrial purposes. The production of the mAb is time and effort intensive. In this report, we established a time- and labor-saving method for the mAb production. Because membrane-type immunoglobulin on a hybridoma cell surface and its secreted form, called as antibody, share the same binding property to the antigen, the fluorescence-labeled antigen bound to membrane-type immunoglobulin can be used as a screening marker. In the method, a hybridoma labeled by a fluorescent antigen was selected and sorted singly into 96-well plate using flow cytometer. Model experiments indicated that the method is highly efficient to obtain good mAbs suitable for Western blotting and immunofluorescence. Notably, most mAbs established by this method belonged to the IgG isotype, which is preferred over the IgM counterpart. Using a high-throughput flow cytometer, the method avoids tedious repeated screening and cloning processes. Because the method uses conventional myeloma for cell fusion and all reagents required in this method are commercially available, all research laboratories can apply the method to obtain mAbs efficiently.
Copyright © 2017 The Society for Biotechnology, Japan. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Flow cytometry; Hybridoma; Monoclonal antibody; Myeloma; Peptide antigen

Mesh:

Substances:

Year:  2017        PMID: 29174537     DOI: 10.1016/j.jbiosc.2017.10.012

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  5 in total

Review 1.  Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives.

Authors:  Hilal Ahmed Parray; Shivangi Shukla; Sweety Samal; Tripti Shrivastava; Shubbir Ahmed; Chandresh Sharma; Rajesh Kumar
Journal:  Int Immunopharmacol       Date:  2020-05-27       Impact factor: 4.932

Review 2.  Nanoscale integration of single cell biologics discovery processes using optofluidic manipulation and monitoring.

Authors:  Marsela Jorgolli; Tanner Nevill; Aaron Winters; Irwin Chen; Su Chong; Fen-Fen Lin; Marissa Mock; Ching Chen; Kim Le; Christopher Tan; Philip Jess; Han Xu; Agi Hamburger; Jennitte Stevens; Trent Munro; Ming Wu; Philip Tagari; Les P Miranda
Journal:  Biotechnol Bioeng       Date:  2019-06-24       Impact factor: 4.530

3.  Nanodisc technology facilitates identification of monoclonal antibodies targeting multi-pass membrane proteins.

Authors:  Bernd Gardill; Jerry Huang; Lawrence Tu; Filip Van Petegem; Kirill Oxenoid; Christy A Thomson
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

4.  Rapid and reliable hybridoma screening method that is suitable for production of functional structure-recognizing monoclonal antibody.

Authors:  Atsumi Sakaguchi; Chika Nakajima; Ayuko Sawano; Yoichiro Tanaka; Yasuyuki Kurihara
Journal:  J Biosci Bioeng       Date:  2021-03-18       Impact factor: 2.894

5.  Efficient human-like antibody repertoire and hybridoma production in trans-chromosomic mice carrying megabase-sized human immunoglobulin loci.

Authors:  Hiroyuki Satofuka; Satoshi Abe; Takashi Moriwaki; Akane Okada; Kanako Kazuki; Hiroshi Tanaka; Kyotaro Yamazaki; Genki Hichiwa; Kayoko Morimoto; Haruka Takayama; Yuji Nakayama; Shinya Hatano; Yutaro Yada; Yasufumi Murakami; Yoshihiro Baba; Mitsuo Oshimura; Kazuma Tomizuka; Yasuhiro Kazuki
Journal:  Nat Commun       Date:  2022-04-05       Impact factor: 17.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.